Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
BONESUPPORT HOLDING AB ( (SE:BONEX) ) has provided an update.
BONESUPPORT announces a leadership transition with Emil Billbäck stepping down as CEO to become a Senior Advisor, and Torbjörn Sköld taking over as CEO effective September 1, 2025. This change is expected to leverage Sköld’s extensive experience in MedTech and orthopedics to further propel the company’s growth and innovation in transforming bone care standards. The transition reflects BONESUPPORT’s strategic focus on maintaining its market-leading position and continuing its growth trajectory.
More about BONESUPPORT HOLDING AB
BONESUPPORT is a leading company in the orthobiologics industry, specializing in innovative injectable bio-ceramic bone graft substitutes that remodel to the patient’s own bone and can elute drugs. Based in Lund, Sweden, the company is known for its patented technology platform and conducts clinical studies to demonstrate the clinical and health economic benefits of its products. In 2024, BONESUPPORT reported net sales of SEK 899 million.
YTD Price Performance: -20.24%
Average Trading Volume: 361
Technical Sentiment Signal: Sell
Current Market Cap: $2.16B
For an in-depth examination of BONEX stock, go to TipRanks’ Stock Analysis page.